Model Informed Drug Development Archives

Publication

Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers

Drug repurposing is promoted as a cost- and time-effective mechanism for providing new medicines. Often,…

Certara2021 年 9 月 23 日

Press Coverage

全新 FDA 指南 Project Optimus 可能如何影响肿瘤学临床试验和药物研究计划的未来

Julie Bullock, VP, global head of clinical pharmacology and translational medicine at Certara, discusses the…

Certara2021 年 8 月 16 日

Blog

Gene Therapy Based Precision Medicine Therapeutics: Clinical Pharmacology & Translational Science Considerations

The era of gene therapy may have started a couple of decades ago, but approvals…

Certara2021 年 8 月 13 日

Case Study

Simcyp™ Simulator 证明了生物等效性 (BE)，无需进行昂贵的临床研究

In this case study, the sponsor’s closing of a manufacturing site required that one of…

Certara2021 年 7 月 29 日

Blog

Maximizing Oligonucleotide Therapeutic Development: Pre-clinical and Translational Considerations

This is the second of three blog posts discussing best practices for developing oligonucleotide therapeutics.…

Certara2021 年 6 月 25 日

Brochure

推动具有影响力的科学成果从实验室走向市场

Learn how Certara drives impactful science.

Certara2021 年 6 月 14 日

Video

Your First Choice in Complex Biologics Drug Development

The pharmaceutical has made massive investments in complex biologics, a drug class that includes oligonucleotide…

Certara2021 年 6 月 1 日

网络研讨会点播

The Wizard of Oligos: There’s no place like having a successful drug development program!

Oligonucleotide therapies— nucleic acid polymers with the potential to treat or manage a wide range…

Certara2021 年 4 月 30 日

Video

Certara (CERT) – Accelerating Medicines with Biosimulation

As seen on CNBC** Certara is the global leader in biosimulation, a powerful and proven…

Certara2021 年 4 月 27 日

On-Demand Webinar

第 3 部分：Oligonucleotide therapeutic development: Clinical pharmacology considerations

In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…

Certara2021 年 4 月 21 日

模型引导的药物开发